Cochrane Abstracts
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once‐daily Versus Multiple‐daily Dosing With Intravenous Aminoglycosides for Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/Once‐daily_versus_multiple‐daily_dosing_with_intravenous_aminoglycosides_for_cystic_fibrosis.
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/Once‐daily_versus_multiple‐daily_dosing_with_intravenous_aminoglycosides_for_cystic_fibrosis. Accessed February 18, 2025.
Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/Once‐daily_versus_multiple‐daily_dosing_with_intravenous_aminoglycosides_for_cystic_fibrosis
Once‐daily Versus Multiple‐daily Dosing With Intravenous Aminoglycosides for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/Once‐daily_versus_multiple‐daily_dosing_with_intravenous_aminoglycosides_for_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once‐daily versus multiple‐daily dosing with intravenous aminoglycosides for cystic fibrosis
ID - 434322
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434322/all/Once‐daily_versus_multiple‐daily_dosing_with_intravenous_aminoglycosides_for_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
